US Stock MarketDetailed Quotes

BCTXW BRIACELL THERAPEUTICS CORP C/WTS(TO PUR COM)

Watchlist
  • 0.220
  • +0.001+0.59%
Close Jul 5 16:00 ET
  • 0.220
  • +0.000+0.05%
Post 16:04 ET
0Market Cap0.00P/E (TTM)

BRIACELL THERAPEUTICS CORP C/WTS(TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
62.58%9.23M
119.10%9.83M
57.37%8.5M
52.25%23.27M
47.22%7.71M
37.68%5.68M
23.13%4.49M
136.48%5.4M
119.23%15.29M
228.12%5.23M
Selling and administrative expenses
-13.46%1.57M
9.70%1.57M
-23.38%1.65M
9.19%7.94M
22.91%2.54M
-2.05%1.82M
-26.08%1.43M
52.43%2.15M
46.67%7.27M
100.60%2.07M
-General and administrative expense
-13.46%1.57M
9.70%1.57M
-23.38%1.65M
9.19%7.94M
22.91%2.54M
-2.05%1.82M
-26.08%1.43M
52.43%2.15M
46.67%7.27M
100.60%2.07M
Research and development costs
98.36%7.66M
170.44%8.26M
110.65%6.86M
91.19%15.34M
63.07%5.17M
70.16%3.86M
78.75%3.05M
271.75%3.26M
296.93%8.02M
445.59%3.17M
Other operating expenses
----
----
----
----
----
----
----
----
8.21%-3.39K
--0
Operating profit
-62.58%-9.23M
-119.10%-9.83M
-57.37%-8.5M
-52.25%-23.27M
-47.22%-7.71M
-37.68%-5.68M
-23.13%-4.49M
-136.48%-5.4M
-119.23%-15.29M
-228.12%-5.23M
Net non-operating interest income expense
-93.84%15.61K
-66.09%81.6K
1.31%190.82K
556.50%891.21K
153.50%208.78K
604.39%253.49K
1,891.52%240.6K
3,436.48%188.35K
280.03%135.75K
69.73%82.36K
Non-operating interest income
-93.84%15.61K
-66.09%81.6K
1.31%190.82K
551.80%891.21K
153.50%208.78K
604.39%253.49K
1,891.52%240.6K
2,887.36%188.35K
4,242.05%136.73K
2,515.37%82.36K
Non-operating interest expense
----
----
----
--0
----
----
----
----
-98.75%979
--0
Other net income (expense)
1,965.18%10.91M
79.23%-1.59M
247.38%14.27M
117.78%2.08M
8.02%5.08M
108.91%528.1K
-151.62%-7.64M
116.27%4.11M
-72.70%-11.69M
132.29%4.7M
Gain on sale of security
1,972.18%10.94M
79.47%-1.57M
247.38%14.27M
117.78%2.08M
8.02%5.08M
108.91%528.1K
-151.62%-7.64M
116.27%4.11M
-76.39%-11.69M
132.15%4.7M
Earnings from equity interest
---37K
---18.35K
----
----
----
--0
--0
----
----
----
Income before tax
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
Income tax
Net income
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
Net income continuous Operations
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
Minority interest income
-23.52K
-39.31K
-42.67K
0
0
0
Net income attributable to the parent company
135.05%1.72M
4.94%-11.29M
642.37%6M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
135.05%1.72M
4.94%-11.29M
642.37%6M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 62.58%9.23M119.10%9.83M57.37%8.5M52.25%23.27M47.22%7.71M37.68%5.68M23.13%4.49M136.48%5.4M119.23%15.29M228.12%5.23M
Selling and administrative expenses -13.46%1.57M9.70%1.57M-23.38%1.65M9.19%7.94M22.91%2.54M-2.05%1.82M-26.08%1.43M52.43%2.15M46.67%7.27M100.60%2.07M
-General and administrative expense -13.46%1.57M9.70%1.57M-23.38%1.65M9.19%7.94M22.91%2.54M-2.05%1.82M-26.08%1.43M52.43%2.15M46.67%7.27M100.60%2.07M
Research and development costs 98.36%7.66M170.44%8.26M110.65%6.86M91.19%15.34M63.07%5.17M70.16%3.86M78.75%3.05M271.75%3.26M296.93%8.02M445.59%3.17M
Other operating expenses --------------------------------8.21%-3.39K--0
Operating profit -62.58%-9.23M-119.10%-9.83M-57.37%-8.5M-52.25%-23.27M-47.22%-7.71M-37.68%-5.68M-23.13%-4.49M-136.48%-5.4M-119.23%-15.29M-228.12%-5.23M
Net non-operating interest income expense -93.84%15.61K-66.09%81.6K1.31%190.82K556.50%891.21K153.50%208.78K604.39%253.49K1,891.52%240.6K3,436.48%188.35K280.03%135.75K69.73%82.36K
Non-operating interest income -93.84%15.61K-66.09%81.6K1.31%190.82K551.80%891.21K153.50%208.78K604.39%253.49K1,891.52%240.6K2,887.36%188.35K4,242.05%136.73K2,515.37%82.36K
Non-operating interest expense --------------0-----------------98.75%979--0
Other net income (expense) 1,965.18%10.91M79.23%-1.59M247.38%14.27M117.78%2.08M8.02%5.08M108.91%528.1K-151.62%-7.64M116.27%4.11M-72.70%-11.69M132.29%4.7M
Gain on sale of security 1,972.18%10.94M79.47%-1.57M247.38%14.27M117.78%2.08M8.02%5.08M108.91%528.1K-151.62%-7.64M116.27%4.11M-76.39%-11.69M132.15%4.7M
Earnings from equity interest ---37K---18.35K--------------0--0------------
Income before tax 134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K
Income tax
Net income 134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K
Net income continuous Operations 134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K
Minority interest income -23.52K-39.31K-42.67K000
Net income attributable to the parent company 135.05%1.72M4.94%-11.29M642.37%6M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 135.05%1.72M4.94%-11.29M642.37%6M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg